Richard Pzena Pzena Investment Management
Richard Pzena is the founder of Pzena Investment Management, a firm specializing in deep-value equities worldwide. The process systematically seeks companies trading at large discounts to normalized earnings power, often when sentiment is poor. Pzena’s research-driven value approach is widely followed by institutional allocators and value-focused individuals.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fresenius Medical Care
FMS
|
+$250M |
| 2 |
Johnson & Johnson
JNJ
|
+$151M |
| 3 |
Cognizant
CTSH
|
+$151M |
| 4 |
NRG Energy
NRG
|
+$96.3M |
| 5 |
Pfizer
PFE
|
+$88.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Textron
TXT
|
+$187M |
| 2 |
Capital One
COF
|
+$116M |
| 3 |
CVS Health
CVS
|
+$103M |
| 4 |
American International
AIG
|
+$74.7M |
| 5 |
Morgan Stanley
MS
|
+$64.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.55% |
| 2 | Consumer Discretionary | 13.6% |
| 3 | Technology | 13.41% |
| 4 | Industrials | 13.17% |
| 5 | Energy | 11.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
ExxonMobil
XOM
$669B
| $337M | 1.33% |
5,726,218
+113,273
| +2% | +$6.46M |
|
27
MetLife
MET
$60.7B
| $328M | 1.3% |
5,316,817
+41,337
| +0.8% | +$2.49M |
|
28
AXIS Capital
AXS
$7.3B
| $327M | 1.29% |
7,102,578
+144,543
| +2% | +$7.17M |
|
29
Voya Financial
VOYA
$8.92B
| $295M | 1.17% |
4,810,089
+83,606
| +2% | +$5.32M |
|
30
Mohawk Industries
MHK
$9.18B
| $282M | 1.12% |
1,590,075
-17,094
| -1% | -$3.31M |
|
31
JPMorgan Chase
JPM
$948B
| $281M | 1.11% |
1,716,239
+32,425
| +2% | +$5.08M |
|
32
Oracle
ORCL
$413B
| $257M | 1.02% |
2,946,834
-344,658
| -10% | -$30.4M |
|
33
Goldman Sachs
GS
$301B
| $241M | 0.95% |
637,421
-73,266
| -10% | -$28.6M |
|
|
34
Fresenius Medical Care
FMS
$12.5B
| $224M | 0.89% |
+6,407,774
| New | +$250M |
|
35
Trip.com Group
TCOM
$28.9B
| $217M | 0.86% |
7,046,589
+918,425
| +15% | +$26.4M |
|
|
36
Pfizer
PFE
$159B
| $216M | 0.86% |
5,021,894
+2,003,764
| +66% | +$88.8M |
|
|
SKX
37
DELISTED
Skechers
SKX
| $196M | 0.78% |
4,653,758
-448,312
| -9% | -$22.2M |
|
38
JELD-WEN Holding
JELD
$206M
| $185M | 0.73% |
7,401,245
+848,614
| +13% | +$22.6M |
|
|
RDS.A
39
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $180M | 0.71% |
4,030,880
-467,398
| -10% | -$18.9M |
|
40
Stanley Black & Decker
SWK
$15B
| $178M | 0.7% |
1,012,492
-19,717
| -2% | -$3.85M |
|
|
41
Morgan Stanley
MS
$338B
| $171M | 0.68% |
1,754,556
-654,722
| -27% | -$64.9M |
|
42
Olin
OLN
$2.03B
| $164M | 0.65% |
3,393,354
-601,820
| -15% | -$28.1M |
|
43
CNO Financial Group
CNO
$5.01B
| $160M | 0.63% |
6,788,861
-239,464
| -3% | -$5.6M |
|
44
TechnipFMC
FTI
$29.3B
| $158M | 0.62% |
20,944,215
-1,574,246
| -7% | -$11.3M |
|
45
Cardinal Health
CAH
$54B
| $146M | 0.58% |
2,956,436
-6,367
| -0.2% | -$345K |
|
|
46
Johnson & Johnson
JNJ
$659B
| $143M | 0.57% |
+885,917
| New | +$151M |
|
47
Ryder
R
$9.44B
| $141M | 0.56% |
1,699,681
-501,997
| -23% | -$38.6M |
|
48
Terex
TEX
$7.52B
| $137M | 0.54% |
3,251,860
-101,737
| -3% | -$4.81M |
|
49
Flex
FLEX
$39.6B
| $137M | 0.54% |
10,249,520
-239,258
| -2% | -$3.22M |
|
50
Cenovus Energy
CVE
$59.5B
| $128M | 0.51% |
12,695,023
-503,325
| -4% | -$4.3M |
|
Similar funds
Richard Pzena's Q3 2021 Portfolio in Review
As of Q3 2021, Richard Pzena held 180 positions worth $25.3B, down 1.7% from $25.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Richard Pzena's Q3 2021 filing shows 15 new, 62 increased, 64 reduced and 12 closed positions. Its largest new stake was Fresenius Medical Care: 6,407,774 shares worth $224M. The largest sale was Textron, an estimated $187M.
By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
- Richard Pzena's largest Q3 2021 buy was Fresenius Medical Care: 6,407,774 shares worth $224M.
- Richard Pzena added most to Cognizant in Q3 2021, an estimated $151M increase.
- Richard Pzena's biggest Q3 2021 reduction was Textron, cutting an estimated $187M.
- Richard Pzena fully exited CVS Health in Q3 2021, selling an estimated $103M.
- Richard Pzena's ten largest holdings make up 35% of its $25.3B portfolio in Q3 2021.
- Richard Pzena opened 15 new positions and closed 12 in Q3 2021.
- Richard Pzena's portfolio value fell 1.7% quarter-over-quarter to $25.3B.
Based on Pzena Investment Management's 13F filing for Q3 2021, filed 5 Nov 2021.